Johnson & Johnson Reports Mixed Fourth-Quarter Results
The world’s largest healthcare company and dividend aristocrat Johnson & Johnson (JNJ) beat earnings expectations but missed on revenue as revenue increases 1.8% year-on-year while adjusted earnings-per-share fell 4.6%. JNJ reported revenue of $20.75 billion, which was just $80 million below the average Wall Street estimate. The adjusted earnings of $1.88 per share surpassed expectations…